Non-small-cell lung cancer (NSCLC)

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

Non-small-cell lung cancer (NSCLC)
Sep 13, 2024, 12:55 | Blog
Shubh G: NeoCOAST and AEGEAN trial results at WCLC
Shubh G, VP, US Franchise Head, Immuno-Oncology and GI Tumors at AstraZeneca, shared a post…
Jun 7, 2024, 04:14 | Cancer Types
Adenocarcinoma of the Lung: What patients should know about
What is Adenocarcinoma of the Lung? Adenocarcinoma of the lung is the most common type…
Apr 23, 2024, 23:25 | Drugs
Jarushka Naidoo: Pooled 5-year outcomes of Pembrolizumab and Chemotherapy for PDL less than 1% metastatic NSCLC in the Journal of Thoracic Oncology
Jarushka Naidoo shared on X: “Pooled 5-yr outcomes of Pembrolizumab and Chemotherapy  for PDL1<1% metastatic…
Apr 17, 2024, 18:39 | Insight
Aruni Ghose: The stellar Giuseppe Banna with his stellar mentee Mona Hassan led this magnificent SR and MA
Aruni Ghose, Internal Medicine Resident at Barts Health NHS Trust and Focused Topic Network Member…
Apr 16, 2024, 13:08 | Blog
Estela Rodriguez: Racial disparities in early-stage NSCLC treatment: A Call for Action
Estela Rodriguez shared on X/Twitter: “Racial disparities in early-stage Non-Small Cell Lung Cancer (NSCLC) treatment: A…
Apr 13, 2024, 08:37 | Insight
New Paper Alert! How concurrent Medication Impacts The Outcomes Of Patients Treated with Immune Checkpoint Inhibitors
How concurrent Medication Impacts The Outcomes Of Patients Treated with Immune Checkpoint Inhibitors Published in…
Apr 12, 2024, 16:43 | Drugs
Tanja Obradovic: Exciting new vaccine is about to start Phase III in advanced NSCLC patients that progressed following immunotherapy
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, recently shared on LinkedIn: “Exciting…
Feb 28, 2024, 12:09 | Blog
Eric K. Singhi: Patrick Forde discusses the nuanced choices thoracic medical oncologists and patients with early-stage Non-small-cell lung cancer (NSCLC) are facing in clinics today
Feb 1, 2024, 15:31 | Opinion
Jarushka Naidoo: Congrats to super fellow David McMahon on his paper addressing a timely topic in thoracic oncology
Jarushka Naidoo shared a post on her X/Twitter page: "Congrats to super fellow David McMahon…
Jan 21, 2024, 07:38 | Blog
Amalya Sargsyan: Is it time to consider SBRT plus SOC as the new standard in managing oligoprogressive NSCLC?
Amalya Sargsyan, Medical Oncologist at the Yeolyan Hematology and Oncology Center, shared a post on…
All: 10 Posts: 1 - 100
Special Coverage